Skip links

9th Annual Immuno-Oncology Summit, October 4–6th, 2021, Boston, MA, US

Meet our new CBO, Brent Meadows, at CHI’s 9th Annual Immuno-Oncology Summit in Boston to learn more about OncoOne’s pipeline of novel, anti-cancer therapies for the treatment of solid tumors and inflammation. Please visit OncoOne at poster #6 entitled “Harnessing oxidized macrophage migration inhibitory factor (oxMIF) as a druggable isoform of MIF for targeted anticancer therapies”.

Home